Stephen L Schensul1, Toan Ha1, Jean J Schensul2, Melita Vaz3, Rajendra Singh4, Joseph A Burleson1, Kendall Bryant5. 1. Department of Community Medicine and Health Care, University of Connecticut School of Medicine, Farmington, Connecticut. 2. Institute for Community Research, Hartford, Connecticut. 3. Population Council, Mumbai, India. 4. International Center for Research on Women, Asia Regional Office, Mumbai, India. 5. National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland.
Abstract
OBJECTIVE: The purpose of this study was to estimate the prevalence of alcohol use among men living with HIV on antiretroviral therapy (ART) and examine the association of alcohol use and psychosocial variables on ART adherence. The study was a cross-sectional survey supplemented by medical records and qualitative narratives as a part of the initial formative stage of a multilevel, multicentric intervention and evaluation project. METHOD: A screening instrument was administered to men living with HIV (n = 3,088) at four ART Centers using the Alcohol Use Disorders Identification Test-consumption questions (AUDIT-C) to determine alcohol use for study eligibility. Alcohol screening data were triangulated with medical records of men living with HIV (n = 15,747) from 13 ART Centers to estimate alcohol consumption among men on ART in greater Mumbai. A survey instrument to identify associations between ART adherence and alcohol, psychosocial, and contextual factors was administered to eligible men living with HIV (n = 361), and in-depth interviews (n = 55) were conducted to elucidate the ways in which these factors are manifest in men's lives. RESULTS: Nearly one fifth of men living with HIV on ART in the Mumbai area have consumed alcohol in the last 30 days. Non-adherence was associated with a higher AUDIT score, consumption of more types of alcohol, and poorer self-ratings on quality of life, depression, and external stigma. The qualitative data demonstrate that non-adherence results from avoiding the mixing of alcohol with medication, forgetfulness when drinking, and skipping medication for fear of disclosure of HIV status when drinking with friends. CONCLUSIONS: As the demand for ART expands, Indian government programs will need to more effectively address alcohol to reduce risk and maintain effective adherence.
OBJECTIVE: The purpose of this study was to estimate the prevalence of alcohol use among men living with HIV on antiretroviral therapy (ART) and examine the association of alcohol use and psychosocial variables on ART adherence. The study was a cross-sectional survey supplemented by medical records and qualitative narratives as a part of the initial formative stage of a multilevel, multicentric intervention and evaluation project. METHOD: A screening instrument was administered to men living with HIV (n = 3,088) at four ART Centers using the Alcohol Use Disorders Identification Test-consumption questions (AUDIT-C) to determine alcohol use for study eligibility. Alcohol screening data were triangulated with medical records of men living with HIV (n = 15,747) from 13 ART Centers to estimate alcohol consumption among men on ART in greater Mumbai. A survey instrument to identify associations between ART adherence and alcohol, psychosocial, and contextual factors was administered to eligible men living with HIV (n = 361), and in-depth interviews (n = 55) were conducted to elucidate the ways in which these factors are manifest in men's lives. RESULTS: Nearly one fifth of men living with HIV on ART in the Mumbai area have consumed alcohol in the last 30 days. Non-adherence was associated with a higher AUDIT score, consumption of more types of alcohol, and poorer self-ratings on quality of life, depression, and external stigma. The qualitative data demonstrate that non-adherence results from avoiding the mixing of alcohol with medication, forgetfulness when drinking, and skipping medication for fear of disclosure of HIV status when drinking with friends. CONCLUSIONS: As the demand for ART expands, Indian government programs will need to more effectively address alcohol to reduce risk and maintain effective adherence.
Authors: Robyn C Neblett; Heidi E Hutton; Bryan Lau; Mary E McCaul; Richard D Moore; Geetanjali Chander Journal: J Womens Health (Larchmt) Date: 2011-01-31 Impact factor: 2.681
Authors: Linda B Cottler; Veena A Satyanarayana; Catina C O'Leary; Krishna Vaddiparti; Vivek Benegal; Prabha S Chandra Journal: AIDS Behav Date: 2010-08
Authors: Basavaprabhu Achappa; Deepak Madi; Unnikrishnan Bhaskaran; John T Ramapuram; Satish Rao; Soundarya Mahalingam Journal: N Am J Med Sci Date: 2013-03
Authors: Francis Bajunirwe; Jessica E Haberer; Yap Boum; Peter Hunt; Rain Mocello; Jeffrey N Martin; David R Bangsberg; Judith A Hahn Journal: PLoS One Date: 2014-12-01 Impact factor: 3.240
Authors: Swagata Tripathy; Upendra Hansda; Newfight Seth; Satyajit Rath; P B Rao; T S Mishra; S H Subba; Rekha Das; Sukdev Nayak; Nilamadhab Kar Journal: Indian J Palliat Care Date: 2015 Sep-Dec
Authors: Toan Ha; Stephen L Schensul; Mitchell Irving; Marie A Brault; Jean J Schensul; Priti Prabhughate; Melita Vaz Journal: AIDS Behav Date: 2019-06
Authors: Emily C Williams; Kathleen A McGinnis; Anna D Rubinsky; Theresa E Matson; Jennifer F Bobb; Gwen T Lapham; E Jennifer Edelman; Derek D Satre; Sheryl L Catz; Julie E Richards; Kendall J Bryant; Brandon D L Marshall; Kevin L Kraemer; Stephen Crystal; Adam J Gordon; Melissa Skanderson; David A Fiellin; Amy C Justice; Katharine A Bradley Journal: AIDS Behav Date: 2021-01
Authors: Stephen L Schensul; Toan Ha; Jean J Schensul; James Grady; Joseph A Burleson; Sushma Gaikwad; Kavita Joshi; Rupal Malye; Avina Sarna Journal: AIDS Behav Date: 2021-05-20
Authors: Jeremy C Kane; Melissa A Elafros; Sarah M Murray; Ellen M H Mitchell; Jura L Augustinavicius; Sara Causevic; Stefan D Baral Journal: BMC Med Date: 2019-02-15 Impact factor: 8.775
Authors: Sarah E Woolf-King; Alan Z Sheinfil; Jeremy Ramos; Jacklyn D Foley; Dezarie Moskal; Madison Firkey; David Kellen; Stephen A Maisto Journal: Health Psychol Rev Date: 2020-08-20